The impact of antegrade continence enemas on bladder function in patients with neurogenic bladder and bowel.
Adolescent
Child
Child, Preschool
Female
Humans
Male
Cholinergic Antagonists
Constipation
/ therapy
Encopresis
Enema
/ methods
Fecal Incontinence
/ therapy
Lower Urinary Tract Symptoms
Neurogenic Bowel
/ complications
Retrospective Studies
Treatment Outcome
Urinary Bladder
/ surgery
Urinary Bladder, Neurogenic
/ etiology
Antegrade continence enema
Chait cecostomy tube
Neurogenic bladder and bowel
Urodynamics
Journal
Journal of pediatric urology
ISSN: 1873-4898
Titre abrégé: J Pediatr Urol
Pays: England
ID NLM: 101233150
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
received:
03
04
2023
revised:
06
07
2023
accepted:
07
07
2023
medline:
2
10
2023
pubmed:
30
7
2023
entrez:
29
7
2023
Statut:
ppublish
Résumé
In neurologically intact children with constipation and lower urinary tract symptoms, treatment of constipation frequently results in improved or resolved lower urinary tract symptoms. The impact of treatment of constipation on bladder function in children with a neurogenic bowel and bladder is not well studied. The objective of this study was to evaluate the impact of antegrade continence enemas (ACE) via Chait tube on urodynamic study (UDS) parameters and urinary continence in patients with neurogenic bowel and bladder (NGB). We hypothesized that following ACE some patients would demonstrate improved UDS parameters and improved urinary continence. A review of patients with NGB who underwent a cecostomy was performed. Inclusion criteria required UDS within 12 months before and after Chait tube placement and no change in clean intermittent catheterization or anticholinergic medications. UDS parameters assessed included bladder capacity, bladder compliance, and bladder stability. In addition, the frequency of antegrade continence enemas and encopresis were reviewed as was the frequency of UTIs before and after the surgery. 8 children met inclusion criteria, including 5 girls and 3 boys, with a mean (range) age of 8.5 years (5-13). All children were on clean intermittent catheterization and 7 were on anticholinergic medications. The patients demonstrated a significant improvement in constipation and encopresis (p < 0.05). All but 1 patient had resolution of encopresis, and 6 of 7 patients who had constipation before ACE management had a resolution of constipation. 2 patients (25%) developed urinary continence (i.e., dry between CIC), and 2 others had improvement in continence. 3, 2, and 2 patients had urodynamic improvement in bladder capacity, compliance, or stability, respectively. However, no significant improvement in urinary incontinence or UDS parameters was demonstrated for the group overall. Our data demonstrate that some children with neurogenic bowel and bladder will have improvement in continence and UDS parameters following the initiation of ACE. Despite significant improvement in constipation and encopresis, the frequency of bladder improvement in this population appears less than that reported in neurologically intact children following treatment of constipation. Confirmatory studies with a larger number of children are needed. However, since constipation appears to negatively impact bladder function in some children with neurogenic bowel and bladder, it is reasonable to try to eliminate significant constipation in these patients before increasing pharmaceutical management of their neurogenic bladder.
Identifiants
pubmed: 37516581
pii: S1477-5131(23)00295-4
doi: 10.1016/j.jpurol.2023.07.005
pii:
doi:
Substances chimiques
Cholinergic Antagonists
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
625.e1-625.e6Informations de copyright
Copyright © 2023 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest None.